Back to Search

ROBERT MCLENDON, MD

MD

Surgery Physician

NPI: 1356682314IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Surgery PhysicianPrimary

Surgery

Code: 208600000X

0101268012(VA)

CMS Specialties

PrimaryGENERAL SURGERY

Education

OTHER

Class of 2013

Research & Publications (20)

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab.
PMID 19647172·Nucl Med Biol·2009
7-preclinical
IDH1 and IDH2 mutations in gliomas.
PMID 19228619·N Engl J Med·2009
8-other
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
PMID 19658188·Stem Cells·2009
7-preclinical
Few isolated neurons in hypothalamic hamartomas may cause gelastic seizures.
PMID 19521137·Pediatr Neurosurg·2009
5-case
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
PMID 19477429·Cancer Cell·2009
7-preclinical
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.
PMID 19185848·Cancer Cell·2009
7-preclinical
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Chordoid glioma: a case report and molecular characterization of five cases.
PMID 18652591·Brain Pathol·2009
5-case
Brain cancer stem cells display preferential sensitivity to Akt inhibition.
PMID 18802038·Stem Cells·2008
7-preclinical
A recurrent cerebellar lesion in a young boy.
PMID 18782180·Brain Pathol·2008
5-case
An integrated genomic analysis of human glioblastoma multiforme.
PMID 18772396·Science·2008
8-other
Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
PMID 18755919·Neuro Oncol·2008
8-other
Targeting cancer stem cells through L1CAM suppresses glioma growth.
PMID 18676824·Cancer Res·2008
7-preclinical
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
PMID 18676759·Clin Cancer Res·2008
8-other
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats.
PMID 18800291·J Toxicol Environ Health A·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
113 GAINSBOROUGH SQ STE 400
CHESAPEAKE, VA 23320

Locations (2)

Practice Location

113 GAINSBOROUGH SQ STE 400, CHESAPEAKE, VA
(757) 842-4499

Practice Location

620 John Paul Jones Cir, Portsmouth, VA
(757) 953-2318

Quick Facts

NPI
1356682314
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
13
Publications
20

Are you this provider?

Claim Your Profile